Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities

v3.24.3
Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities - shares
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Common share equivalents and dilutive securities 2,014,209,631 1,919,036,011
Series B preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Common share equivalents and dilutive securities 357,819,360 327,376,230
Series C preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Common share equivalents and dilutive securities 400,468,718 403,380,750
Convertible debt [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Common share equivalents and dilutive securities 1,215,950,855 1,145,833,333
Stock options [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Common share equivalents and dilutive securities 6,770,698 8,445,698
Warrants [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Common share equivalents and dilutive securities 33,200,000 34,000,000